Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage

Blood

Volumn 92, Issue 9, 1998, Pages 3226-3239

  Zhou, Ping ^a   Qian, Liping ^a   Bieszczad, Christine K ^a   Noelle, Randolph ^a   Binder, Michael ^a   Levy, Norman B ^a   Craig, Ruth W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL VIABILITY; HEMATOPOIESIS; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0032211158     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3226     Document Type: Article

References (63)

1. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 90:3516, 1993
2. Zhou P, Qian L, Kozopas KM, Craig RW: Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89:630, 1997
3. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 54:6348, 1994
4. Bodrug SE, Aime-Sempe C, Takaaki S, Krajewski S, Hanada M, Reed JC: Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Differ 2:173, 1995
5. Yang T, Kozopas KM, Craig RW: The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol 128:1173, 1995
6. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC: Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146:1309, 1995
7. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991
8. Carrio R, Lopez-Hoyos M, Jimeno J, Benedict MA, Merino R, Benito A, Fernandez -Luna JL, Nunez G, Garcia-Porrero JA, Merino J: A1 demonstrates restricted tissue distribution during embryonic development and functions to protect against cell death. Am J Path 149:2133, 1996
9. Cory S: Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 13:513, 1995
10. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1989
11. McDonnell TJ, Nunez G, Platt FM, Hockenberry D, London L, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 10:1901, 1990
12. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
13. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW: Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661, 1991
14. Grillot DA, Merino R, Nunez G: Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med 182:1973, 1995
15. Grillot DA, Merino R, Pena JC, Fanslow WC, Finkelman FD, Thompson CB, Nunez G: bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med 183:381, 1996
16. Ma A, Pena JC, Chang B, Margosian E, Davidson L, Alt FW, Thompson CB: Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad Sci USA 92:4763, 1995
17. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DH: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506, 1995
18. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229, 1993
19. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823, 1993
20. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL: Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955, 1994
21. Akashi K, Konda M, von Freeden-Jeffry U, Murray R, Weissman IL: Bcl-2 recsues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89:1033, 1997
22. Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A: Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/-mice. Cell 89:1011, 1997
23. Lagasse E, Weissman IL: Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021, 1997
24. Lin EY, Orlofsky A, Wang HG, Reed JC, Prystowsky MB: A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87:983, 1996
25. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
26. Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331, 1990
27. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349:254, 1991
28. Strasser A, Elefanty AG, Harris AW, Cory S: Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J 15:3823, 1996
29. Crapper RM, Schrader JW: Frequency of mast cell precursors in normal tissues determined by an in vitro assay: Antigen induces parallel increases in the frequency of P cell precursors and mast cells. J Immunol 131:923, 1983
30. Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D: Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med 152:1036, 1980
31. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2931, 1983
32. Schrader JW: In in vitro production and cloning of the P cell, a bone marrow-derived null cell that expresses H-2 and la-antigens, has mast cell-like granules, and is regulated by a factor released by activated T cells. J Immunol 126:452, 1981
33. Schrader JW, Lewis SJ, dark-Lewis I, Culvenor JG: The persisting (P) cell: Histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. Proc Natl Acad Sci USA 78:323, 1981
34. Spooncer E, Boettiger D, Dexter TM: Continuous in vitro generation of multipotential stem cell clones from src-infected cultures. Nature 310:228, 1984
35. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning, A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989, p 1.42
36. Hogan B, Beddington R, Costantini F, Lacy E: Manipulating the Mouse Embryo, A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1994, p 228
37. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA fragments to high specific activity. Anal Biochem 132:6, 1983
38. McCann FV, McCarthy DC, Noelle RJ: Patch-clamp profile of ion channels in resting murine B lymphocytes. J Membr Biol 114:175, 1990
39. Craig RW, Frankfurt OS, Sakagami H, Takeda K, Block A: Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells. Cancer Res 44:2421, 1984
40. Lee JC, Hapel AJ, Ihle JN: Constitutive production of a unique lymphokine (IL-3) by WEHI-3 cell line. J Immunol 128:2393, 1982
41. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD: Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nat Genet 5:22, 1993
42. Ezaki O, Flores-Riveros JR, Kaestner KH, Gearhart JD, Lane MD: Regulated expression of an insulin-responsive glucose transporter (GLUT4) minigene in 3T3-L1 adipocytes and transgenic mice. Proc Natl Acad Sci USA 90:3348, 1993
43. Bustin M, Alfonso PJ, Pash JM, Ward JM, Gearhart JD, Reeves RH: Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. DNA Cell Biol 14:997, 1995
44. Semenza GL, Dureza RC, Traystman MD, Gearhart JD, Antonarakis SE: Human erythropoietin gene expression in transgenic mice: Multiple transcription initiation sites and cis-acting regulatory elements. Mol Cell Biol 10:930, 1990
45. Heyman RA, Borrelli E, Lesley J, Anderson D, Richman DD, Baird SM, Hyman R, Evans RM: Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci USA 86:2698, 1989
46. Freitas AA, Rocha BB: Lymphocyte lifespans: Homeostasis, selection and competition. Immunol Today 14:25, 1993
47. Foley KP, McArthur GA, Queva C, Hurlin PJ, Soriano P, Eisenman RN: Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J 17:774, 1998
48. de Bruijn MF, Slicker WA, van der Loo JC, Voerman JS, van Ewijk W, Leenen PJ: Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol 24:2279, 1994
49. Slicker WA, de Rijk-de Bruijn MF, Leenen PJ, van Ewijk W: ER-MP12 antigen, a new cell surface marker on mouse bone marrow cells with thymus-repopulating ability: I. Intrathymic repopulating ability of ER-MP12-positive bone marrow cells. International Immunology 5:1093, 1993
50. van der Loo JC, Slicker WA, Kieboom D, Ploemacher RE: Identification of hematopoietic stem cell subsets on the basis of their primitiveness using antibody ER-MP12. Blood 85:952, 1995
51. van der Loo JC, Slicker WA, Ploemacher RE: Use of ER-MP12 as a positive marker for the isolation of murine long-term in vitro repopulating stem cells. Exp Hem 23:1002, 1995
52. Park JR, Robertson K, Hickstein DD, Tsai S, Hockenbery DM, Collins SJ: Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84:440, 1994
53. Strasser A, Harris AW, Cory S: bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
54. Lagasse E, Weissman IL: bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 179:1047, 1994
55. Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, Wellner D, Leder P, Besmer P: The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225, 1990
56. Rodewald HR, Dessing M, Dvorak AM, Galli SJ: Identification of a committed precursor for the mast cell lineage. Science 271:818, 1996
57. Rottem M, Okada T, Goff JP, Metcalfe DD: Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI-cell population. Blood 84:2489, 1994
58. Mekori YA, Oh CK, Metcalfe DD: IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 151:3775, 1993
59. Dexter T, Testa N: Differentiation and proliferation of hemopoietic cells in culture. Methods Cell Biol 14:387, 1976
60. Lin EY, Orlofsky A, Berger MS, Prystowsky MB: Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151:1979, 1993
61. Perkins AC, Cory S: Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. EMBO J 12:3835, 1993
62. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279:349, 1998
63. Nagao K, Yokoro K, Aaronson SA: Continuous lines of basophil/ mast cells derived from normal mouse bone marrow. Science 212:333, 1981